Abstract
• Two recent surveys on oral chemotherapy from Spain and France provide novel data in a European setting on this field. • Depending on the country, oral chemotherapy can be dispensed by community pharmacists or by hospital pharmacists, with notable differences in their involvement in the safety practices. • It is valuable to have a hospital pharmacist with experienced in oncology to be directly involved in the education also when an oral antineoplastic agent is dispensed to minimize potential errors, improve patient outcomes and compliance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
